# ANCA‐Negative Granulomatosis With Polyangiitis Mimicking Sinusitis and Rhinoscleroma: A Case Report

**Authors:** Sergey Gorbunov, Georgiy Polev

PMC · DOI: 10.1155/carm/4144957 · 2026-02-26

## TL;DR

A 65-year-old woman with ANCA-negative GPA was misdiagnosed with sinusitis for months, highlighting the importance of considering rare autoimmune diseases even when blood tests are negative.

## Contribution

This case report adds to the understanding of ANCA-negative GPA by illustrating its atypical presentation and diagnostic challenges.

## Key findings

- ANCA-negative GPA can mimic chronic sinusitis and rhinoscleroma, leading to delayed diagnosis.
- Early immunosuppressive treatment in GPA is crucial to prevent severe organ damage.
- Clinical suspicion is essential when serological markers are absent but systemic progression is evident.

## Abstract

This case details the diagnostic challenge of ANCA‐negative granulomatosis with polyangiitis (GPA) initially presenting as refractory chronic rhinosinusitis, mimicking recurrent infections, and other granulomatous conditions. It highlights the potential for significant diagnostic delay when serological markers are absent.

A 65‐year‐old female with recurrent sinusitis underwent multiple antibiotic regimens and endoscopic sinus surgery. Despite this, she developed progressive destructive manifestations over 10 months: nasal septal perforation, saddle nose deformity, keratouveitis with exophthalmos, macrohematuria, and a lacunar cerebellar infarct. Serial microbiology showed various pathogens; histology initially suggested rhinoscleroma. ANCA remained negative.

Following the clinical diagnosis of ANCA‐negative GPA, therapy with rituximab and corticosteroids was initiated, leading to significant improvement and sustained remission on maintenance immunosuppression.

This case demonstrates that ANCA‐negative GPA can present as refractory sinonasal disease. Negative serology does not exclude GPA; a high clinical suspicion is warranted in cases with destructive features and systemic progression. Early immunosuppressive treatment is essential to prevent severe organ damage.

## Linked entities

- **Diseases:** rhinoscleroma (MONDO:0005945)

## Full-text entities

- **Genes:** KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, RNPC3 (RNA binding region (RNP1, RRM) containing 3) [NCBI Gene 55599] {aka CPHD7, IGHD5, RBM40, RNP, SNRNP65}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, EXOSC10 (exosome component 10) [NCBI Gene 5394] {aka PM-Scl, PM/Scl-100, PMSCL, PMSCL2, RRP6, Rrp6p}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, PRTN3 (proteinase 3) [NCBI Gene 5657] {aka ACPA, AGP7, C-ANCA, CANCA, MBN, MBT}, MPO (myeloperoxidase) [NCBI Gene 4353], DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, SSB (small RNA binding exonuclease protection factor La) [NCBI Gene 6741] {aka LARP3, La, La/SSB, SSB/La}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}
- **Diseases:** mastoid inflammation (MESH:D008417), Granulomatosis (MESH:D015267), hematuria (MESH:D006417), Sinusitis (MESH:D012852), autoimmune vasculitis (MESH:D014657), granulomatous conditions (MESH:D020763), saddle (MESH:C536025), granulomatous inflammation (MESH:D007249), fibrosis (MESH:D005355), syphilis (MESH:D013587), edema (MESH:D004487), epithelial malignancy (MESH:D002277), renal failure (MESH:D051437), ANCA (MESH:D056648), benign tumors (MESH:D009369), stroke (MESH:D020521), nasal septal perforation (MESH:D061270), hyperplastic pansinusitis (MESH:D000082242), septal perforation (MESH:D018658), otitis media (MESH:D010033), Rhinoscleroma (MESH:D012226), odontogenic maxillary sinusitis (MESH:D015523), exophthalmos (MESH:D005094), facial pain (MESH:D005157), proteinuria (MESH:D011507), viral hepatitis (MESH:D014777), photophobia (MESH:D020795), GPA (MESH:D014890), anemia (MESH:D000740), NK/T-cell lymphoma (MESH:D016399), sinonasal disease (MESH:C535701), dry eyes (MESH:D015352), bone defect (MESH:D001847), osteitis (MESH:D010000), dizziness (MESH:D004244), Renal involvement (MESH:C565423), infection (MESH:D007239), perforation (MESH:D057112), systemic vasculitis (MESH:D056647), cerebellar infarct (MESH:D007238), organ damage (MESH:D000092124), lymphoproliferative disorders (MESH:D008232), Negative (MESH:D064726), chronic (MESH:D002908), fungal sinusitis (MESH:D000092562), necrosis (MESH:D009336)
- **Chemicals:** mycophenolate (MESH:D009173), doxycycline (MESH:D004318), ciprofloxacin (MESH:D002939), clindamycin (MESH:D002981), methicillin (MESH:D008712), chlorhexidine (MESH:D002710), penicillins (MESH:D010406), prednisolone (MESH:D011239), linezolid (MESH:D000069349), rifampicin (MESH:D012293), cephalosporins (MESH:D002511), Rituximab (MESH:D000069283), trimethoprim/sulfamethoxazole (MESH:D015662), fluconazole (MESH:D015725), prednisone (MESH:D011241), steroids (MESH:D013256)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Klebsiella oxytoca (species) [taxon 571], Staphylococcus lugdunensis (species) [taxon 28035], Staphylococcus epidermidis (species) [taxon 1282], Candida [taxon 1535326], Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Staphylococcus aureus (species) [taxon 1280], Alternaria alternata (species) [taxon 5599]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943459/full.md

---
Source: https://tomesphere.com/paper/PMC12943459